首页> 外文期刊>Rambam Maimonides Medical Journal >Pecuniary and Non-Pecuniary Incentives to Increase the Rate of Organ Donations from the Living: A Moral Exploration
【24h】

Pecuniary and Non-Pecuniary Incentives to Increase the Rate of Organ Donations from the Living: A Moral Exploration

机译:金钱和非金钱激励措施,以增加活体器官捐赠的比率:一种道德探索

获取原文
获取外文期刊封面目录资料

摘要

This paper examines the morality of schemes of payment to live donors/sellers of organs for transplantation. Following empirical and historical evidence, it is argued that consent to sell organs is substantially different from consent to ordinary business transactions and that legalization of exchanges of organs with financial benefits deviates significantly from the scope of liberal toleration and liberal conceptions of human rights. Although altruistic giving is commendable, it is immoral for society to benefit from them without conferring to the donors benefits such as health and nursing insurance for life. Non-alienable and non-fungible benefits of this kind are moral as incentives to organ donation/giving.Keywords: Organ transplantation, live donors, financial incentives/rewards, market in organs, altruistic donationINTRODUCTIONEvery day patients die while on a waiting list for kidney transplantation. Many cadaveric organs are not transplanted because of legal constraints or refusal of next of kin. Anybody who is committed to the value of life and human dignity cannot accept this grim situation.In many places of the world, money is offered to healthy people in exchange of a kidney donation. Similar schemes might be conceived regarding lobes of lung and liver. The probity of pecuniary payments, compensations, or incentives offered to such so-called donors is hotly debated worldwide.Language is a central player in the debate, as the very vocabulary used predetermines much of the discussion. Therefore, in this paper I use words such as “donors” and” sellers” as synonyms, and instead of the terms “compensation” and “payments” I speak about “pecuniary incentives”, having in mind all sorts of cash or liquid benefits that are offered to people in order to encourage them to give a kidney for the sake of transplantation in a needy patient.In the forthcoming discussion I will argue that fungible incentives are immoral and should be prohibited even if they are likely to increase the rate of transplantation and of health indexes overall; and that society should offer some non-fungible incentives or rewards to every live donor regardless of the motivation or whether he or she asks for it.This paper discusses kidneys, because kidney transplantations considerably outnumber other forms of organ transplantation. The discussion, however, is relevant to any form of transplantation that may originate from live donors. Kidney and liver lobes are two notable examples.AN OVERVIEW OF DIFFERENT MODES OF ORGAN PROCUREMENTOf all possible schemes of organ procurement, only one benefits from public consensus – altruistic donations (including presumed consent to donate altruistically) from either the living or the dead. Consensus prevails also with regard to two prohibitions – against non-consensual harvest from live donors and against consensual but harmful removal (e.g. a parent with a single kidney who wishes to donate to a child). Although the ethics of one scheme may depend on the morality of another, the academic literature on organ procurement tends to focus each time on a single scheme. For example, it seems reasonable to assume that the morality of markets in organs from the living may depend on whether non-consensual harvest from the dead is practiced first or whether all potentially eligible cadaveric kidneys have been used. But publications promoting markets in organs ignore this approach (e.g. Cherry1).Currently, there is some literature in favor of non-consensual harvest from the dead; more intense is the debate on markets for organs from the living. The two approaches aim at expanding the availability of organs, but they are not conceptually compatible with each other. Support for non-consensual harvest from the dead is based on utilitarian considerations, whereas libertarians typically respect every personal choice including the choice to sell one’s own kidney at “market price”. The utilitarians are committed to the fair promotion of p
机译:本文探讨了向活体器官移植供者/卖方付款计划的道德性。根据经验和历史证据,有人认为同意出售器官与对普通商业交易的同意有很大不同,具有经济利益的器官交换的合法化大大偏离了自由宽容和自由人权概念的范围。尽管无私奉献是值得称赞的,但在不给予捐赠者诸如健康和终身护理保险等利益的情况下,从中受益是不道德的。此类不可转让和不可替代的好处在道德上是鼓励器官捐赠/给予的激励措施。移植。由于法律限制或拒绝亲属,许多尸体器官未移植。任何致力于生命价值和人格尊严的人都无法接受这种严峻的形势。在世界上许多地方,金钱都是通过向肾脏捐赠来向健康人提供的。关于肺叶和肝叶,可以设想类似的方案。提供给所谓的捐助者的金钱付款,补偿或激励的可能性在全球范围内都受到激烈的辩论。语言是辩论的中心人物,因为所用的词汇是很多讨论的前提。因此,在本文中,我使用诸如“捐赠者”和“卖方”之类的词作为同义词,在考虑到各种现金或流动利益的情况下,我谈论的不是“补偿”和“支付”,而是“金钱激励”。提供给人们的目的是为了鼓励他们为有需要的患者移植而移植肾脏。在即将进行的讨论中,我将辩称,可替代的诱因是不道德的,即使它们可能会增加患病率,也应予以禁止。移植和总体健康指标;社会应该为每一个活体捐献者提供一些不可替代的激励或奖励,而不考虑其动机或是否要求助。本文讨论了肾脏,因为肾脏移植大大超过了其他形式的器官移植。但是,该讨论与可能来自活体供体的任何形式的移植有关。肾脏和肝叶是两个著名的例子。不同器官采购模式的概述在所有可能的器官采购计划中,只有一个受益于公众共识–活人或死人的无私捐赠(包括假定的无偿捐赠)。在两个禁止方面也普遍存在共识-禁止从活体供体中以非自愿方式进行收获,以及禁止以自愿但有害的方式进行采摘(例如,有单个肾脏的父母希望向孩子捐款)。尽管一种方案的伦理可能取决于另一种方案的道德性,但有关器官采购的学术文献往往每次都集中于一个方案。例如,似乎合理的假设是,活体器官市场的道德性可能取决于是否首先进行了死者的非自愿收获,或者是否已经使用了所有可能合格的尸体肾脏。但是,促进器官市场的出版物却忽略了这种方法(例如Cherry1)。目前,有一些文献赞成从死者那里以非自愿的方式收获。关于活体器官市场的争论更加激烈。两种方法旨在扩大器官的可用性,但是它们在概念上并不兼容。对死者进行非自愿收获的支持是基于功利主义的考虑,而自由主义者通常会尊重每个人的选择,包括以“市场价格”出售自己的肾脏的选择。功利主义者致力于公平推广

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号